✦ LIBER ✦

PMS33 COST-EFFECTIVENESS OF TOCILIZUMAB FOR THE MANAGEMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE PREVIOUS DMARD THERAPY IN MEXICO

✍ Scribed by F Carlos; A Aguirre; I Peláez-Ballestas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS36 COST-EFFECTIVENESS OF TOCILIZUMAB

✍ F Carlos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMS35 Cost-Effectiveness of Tocilizumab

✍ I. Ertenli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMS22 COST-EFFECTIVENESS OF THE USE OF E

✍ X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh; R Rivera; E García; H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

PMS33 Cost-Efficacy Analysis of Biologic

✍ A. Cafe; I. Monteiro; J.F. Loff; R. Encarnação 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMS5 COST-EFFECTIVENESS OF THE USE OF ET

✍ Aguirre, A; García, E; Bierschwale, H; Arce, CA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PMS30 Cost-Effectiveness of Tocilizumab

✍ A. Diamantopoulos; S. Andrade; A. Bernardo; J. Branco; L. Inês; J.A. Pereira da 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB